Antibody May Reverse Some Alzheimer’s Symptoms

	Tweet

A special protein can be injected into the body to reverse learning problems in mice that have an animal version of Alzheimer’s disease, Saint Louis University researchers have found.

The protein—part of the immunoglobulin M (IgM) class—is an antibody that grabs onto the amyloid beta protein in the brain and prevents it from changing into the toxic substance believed to cause Alzheimer’s disease.

“Our research in an animal model showed that antibodies can be developed rationally for treating Alzheimer’s disease,” says William A. Banks, M.D. professor of geriatrics and pharmacological and physiological science at Saint Louis University. “It’s a major thing that people have been trying to do – get antibodies into the brain in the right amount to treat illnesses. This antibody does that.”

Banks says the findings are surprising because IgM is five times bigger than the antibody immunoglobulin G (IgG), which has already been studied as a potential therapy for Alzheimer’s disease. Because it is larger, scientists didn’t believe it could cross the blood-brain barrier, a protective membrane that keeps foreign substances out of the brain.

“We collaborated with Michael Steinitz from Hebrew University in Jerusalem, who developed an antibody that is part of the IgM class of antibodies that would stick better to amyloid beta protein,” says Banks, who also is a staff physician at Veterans Affairs Medical Center in St. Louis Banks says.

“This compound had better entry to the brain than IgG, even though they are smaller.”

A single intravenous dose of IgM reversed cognitive impairment in aged mice that have a genetic mutation that causes deficits similar to those found in patients with Alzheimer’s disease, Banks says.

The findings were published in the August issue of Experimental Neurology.

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first M.D. degree west of the Mississippi River. Saint Louis University School of Medicine is a pioneer in geriatric medicine, organ transplantation, chronic disease prevention, cardiovascular disease, neurosciences and vaccine research, among others. The School of Medicine trains physicians and biomedical scientists, conducts medical research, and provides health services on a local, national and international level.

Source: Saint Louis University Medical Center

RELATED STORIES:
Specific changes in the brain associated with sleep deprivation described in new study   The faces of Alzheimer’s   Virtual reality may speed recovery after stroke   Being downsized may increase stroke risk   Evidence of a genetic risk factor for Parkinson’s disease   Genetic Mutation Associated with Famous Alzheimer Patient May Have Been Identified   U.S. approves blood test to screen for stroke risk   Are all meditation techniques the same?   Risk Takers May Have Lower Rates of Parkinson’s Disease   More Evidence That Alzheimer’s Disease May Be Inherited from Your Mother   Are Seizures Due to Cerebral Hemorrhage Going Undiagnosed in the ICU?   New Treatment for Stroke Works up to a Day After Symptoms Start

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]